Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes

被引:0
|
作者
Khan, Ahsan Ali [1 ]
Khalid, Muhammad Usman [1 ]
Bajwa, Mohammad Hamza [1 ]
Urooj, Faiza [1 ]
Tahir, Izza [2 ]
Angez, Meher [2 ]
Zahid, Fahad [1 ]
Baqai, Muhammad Waqas Saeed [1 ]
Aftab, Kiran [1 ]
Ansari, Shahabuddin [3 ]
Khan, Ummul Wara [1 ]
Ahmed, Ali Azan [2 ]
Enam, Syed Ather [1 ]
机构
[1] Aga Khan Univ, Dept Surg, Karachi, Pakistan
[2] Aga Khan Univ, Med Coll, Karachi, Pakistan
[3] GIK Inst Engn Sci & Technol, Dept Comp Sci, Topi, Pakistan
关键词
Circumscribed; Infiltrating; Lower-grade; Glioma; Clinical outcomes; Radiological features; CENTRAL-NERVOUS-SYSTEM; TUMORS; MUTATIONS;
D O I
10.1016/j.wnsx.2024.100356
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We hypothesize that lower grade gliomas (LGG) can be identified and classified into two distinct subtypes: radiologically circumscribed Lower-Grade Gliomas (cLGG) and infiltrating Lower-Grade Gliomas (iLGG) based on radiological parameters and that these two different subtypes behave differently in terms of clinical outcomes. Methods: We conducted a retrospective cohort study on surgical patients diagnosed with lower grade glioma over five years. Patient records and MRIs were reviewed, and neurosurgeons classified tumors into cLGG and iLGG groups. Results: From the 165 patients in our cohort, 30 (18.2%) patients were classified as cLGG and 135 (81.8%) patients were classified as iLGG Mean age in cLGG was 31.4 years while mean age in iLGG was 37.9 years (p = 0.004). There was significant difference in mean blood loss between cLGG and iLGG groups (270 and 411 ml respectively, p = 0.020). cLGG had a significantly higher proportion of grade II tumors (p < 0.001). The overall mean survival time for the iLGG group was 14.96 +/- 1.23 months, and 18.77 +/- 2.72 months for the cLGG group. In univariate cox regression, the survival difference between LGG groups was not significant (HR = 0.888, p = 0.581), however on multivariate regression cLGG showed a significant (aHZ = 0.443, p = 0.015) positive correlation with survival. Intense contrast enhancement (HZ = 41.468, p = 0.018), blood loss (HZ = 1.002, p = 0.049), and moderately high Ki-67 (HZ = 4.589, p = 0.032) were also significant on univariate analyses. Conclusion: cLGG and iLGG are radiologically distinct groups with separate prognoses, surgical experience, and associations.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
    Chan, Aden Ka-Yin
    Yao, Yu
    Zhang, Zhenyu
    Chung, Nellie Yuk-Fei
    Liu, Joseph Shu-Ming
    Li, Kay Ka-Wai
    Shi, Zhifeng
    Chan, Danny Tat-Ming
    Poon, Wai Sang
    Zhou, Liangfu
    Ng, Ho-Keung
    MODERN PATHOLOGY, 2015, 28 (02) : 177 - 186
  • [42] Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas
    Tokunori Kanazawa
    Hirokazu Fujiwara
    Hidenori Takahashi
    Yuya Nishiyama
    Yuichi Hirose
    Saeko Tanaka
    Kazunari Yoshida
    Hikaru Sasaki
    Neurosurgical Review, 2019, 42 : 433 - 441
  • [43] An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
    Zhang, Hongbo
    Li, Xuesong
    Li, Yuntao
    Chen, Baodong
    Zong, Zhitao
    Shen, Liang
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [44] Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas
    Hayes, Josie
    Yu, Yao
    Jalbert, Llewellyn E.
    Mazor, Tali
    Jones, Lindsey E.
    Wood, Matthew D.
    Walsh, Kyle M.
    Bengtsson, Henrik
    Hong, Chibo
    Oberndorfer, Stefan
    Roetzer, Thomas
    Smirnov, Ivan V.
    Clarke, Jennifer L.
    Aghi, Manish K.
    Chang, Susan M.
    Nelson, Sarah J.
    Woehrer, Adelheid
    Phillips, Joanna J.
    Solomon, David A.
    Costello, Joseph F.
    NEURO-ONCOLOGY, 2018, 20 (05) : 632 - 641
  • [45] Combination genetic signature stratifies lower-grade gliomas better than histological grade
    Chan, Aden Ka-Yin
    Yao, Yu
    Zhang, Zhenyu
    Shi, Zhifeng
    Chen, Liang
    Chung, Nellie Yuk-Fei
    Liu, Joseph Shu-Ming
    Li, Kay Ka-Wai
    Chan, Danny Tat-Ming
    Poon, Wai Sang
    Wang, Ying
    Zhou, Liangfu
    Ng, Ho-Keung
    ONCOTARGET, 2015, 6 (25) : 20885 - 20901
  • [46] Neuro-oncological superiority of supratotal resection in lower-grade gliomas
    Gallotti, Alberto L.
    Rossi, Marco
    Nibali, Marco Conti
    Sciortino, Tommaso
    Gay, Lorenzo G.
    Puglisi, Guglielmo
    Leonetti, Antonella
    Bruno, Francesco
    Ruda, Roberta
    Soffietti, Riccardo
    Cerri, Gabriella
    Bello, Lorenzo
    NEURO-ONCOLOGY, 2025,
  • [47] Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas
    Kanazawa, Tokunori
    Fujiwara, Hirokazu
    Takahashi, Hidenori
    Nishiyama, Yuya
    Hirose, Yuichi
    Tanaka, Saeko
    Yoshida, Kazunari
    Sasaki, Hikaru
    NEUROSURGICAL REVIEW, 2019, 42 (02) : 433 - 441
  • [48] IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas
    Duan, Wen-chao
    Wang, Li
    Li, Ke
    Wang, Wei-wei
    Zhan, Yun-bo
    Zhang, Feng-jiang
    Yu, Bin
    Bai, Ya-hui
    Wang, Yan-min
    Ji, Yu-chen
    Zhou, Jin-qiao
    Liu, Xian-zhi
    Zhang, Zhen-yu
    MEDICINE, 2018, 97 (50)
  • [49] IDH mutation-specific radiomic signature in lower-grade gliomas
    Liu, Xing
    Li, Yiming
    Li, Shaowu
    Fan, Xing
    Sun, Zhiyan
    Yang, Zhengyi
    Wang, Kai
    Zhang, Zhong
    Jiang, Tao
    Liu, Yong
    Wang, Lei
    Wang, Yinyan
    AGING-US, 2019, 11 (02): : 673 - 696
  • [50] Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline
    Sienkiewicz, Karolina
    Ratan, Aakrosh
    STAR PROTOCOLS, 2022, 3 (01):